EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: April 2019

NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board

April 10, 2019

Company advances NT-0167 as first development candidate from a broad platform of NLRP3 inflammasome inhibitors Appoints Don Nicholson as Board Chairman and Kevin Lee as

Read »

IGEM Therapeutics Appoints Dr David Chiswell as a Non-Executive Chairman

April 9, 2019

Cambridge Antibody Technology co-founder and CEO, Dr Chiswell brings 30 years of biotechnology experience to IGEM’s Board London, 9 April 2019 – IGEM Therapeutics (IGEM),

Read »

EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: April 2019

NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board

IGEM Therapeutics Appoints Dr David Chiswell as a Non-Executive Chairman

Categories

Archives